Evidence map›Paper›PMID 30097539›Full record

ArticleGenome research2018

Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed binding.

Ian C McDowell, Alejandro Barrera, Anthony M D'Ippolito, Christopher M Vockley, Linda K Hong, Sarah M Leichter, Luke C Bartelt, William H Majoros, Lingyun Song, Alexias Safi and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Genome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome.The Journal of clinical endocrinology and metabolism · 2024
    Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Ian C McDowellGraduate Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina 27708, USA.
Alejandro BarreraCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Anthony M D'IppolitoCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Christopher M VockleyCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Linda K HongCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Sarah M LeichterCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Luke C BarteltCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
William H MajorosGraduate Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina 27708, USA.
Lingyun SongCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Alexias SafiCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
D Dewran KoçakCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Charles A GersbachCenter for Genomic and Computational Biology, Duke University, Durham, North Carolina 27708, USA.
Alexander J HarteminkGraduate Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina 27708, USA.
Gregory E CrawfordGraduate Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina 27708, USA.
Barbara E EngelhardtDepartment of Computer Science, Princeton University, Princeton, New Jersey 08540, USA.
Timothy E ReddyGraduate Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina 27708, USA.
Duke University · USPrinceton University · US

Funding

Decoding and Reprogramming the Corticosteroid Transcriptional Regulatory NetworkU01HG007900 · NHGRI · DUKE UNIVERSITY · PI REDDY, TIMOTHY E · 2015 to 2017
$5.9M
Computational Biology and Bioinformatics Training ProgramT32GM071340 · NIGMS · DUKE UNIVERSITY · PI MAGWENE, PAUL MITAARI · 2005 to 2020
$3.3M
Engineering Targeted Epigenetic Modifiers for Precise Control of Gene RegulationR01DA036865 · NIDA · DUKE UNIVERSITY · PI CRAWFORD, GREGORY E, GERSBACH, CHARLES A. · 2013 to 2017
$2.6M
Identification and validation of cell specific eQTLs by Bayesian modelingR01MH101822 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BROWN, CHRISTOPHER DAVID, ENGELHARDT, BARBARA · 2013 to 2016
$1.9M
Exploring the Role of Dynamic Chromatin Occupancy in Transcriptional RegulationR01GM118551 · NIGMS · DUKE UNIVERSITY · PI HARTEMINK, ALEXANDER J · 2016 to 2019
$1.6M
Statistical models to investigate long-distance QTL transcription regulationR00HG006265 · NHGRI · PRINCETON UNIVERSITY · PI ENGELHARDT, BARBARA · 2012 to 2014
$747k
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
Trans-regulatory mechanisms of glucocorticoid-mediated transcriptional repressionF31AI124563 · NIAID · DUKE UNIVERSITY · PI D'IPPOLITO, ANTHONY · 2016 to 2017
$61k
Testing novel models of glucocorticoid-induced transcription regulationF31HL129743 · NHLBI · DUKE UNIVERSITY · PI VOCKLEY, CHRISTOPHER · 2015 to 2015
$34k
NHGRI NIH HHS R00 HG006265NHGRI NIH HHS U01 HG007900NHLBI NIH HHS F31 HL129743NIAID NIH HHS F31 AI124563NIDA NIH HHS R01 DA036865NIGMS NIH HHS R01 GM118551NIGMS NIH HHS T32 GM071340NIH HHS S10 OD018164NIMH NIH HHS R01 MH101822
6 · The paper itself

Abstract

Glucocorticoids are potent steroid hormones that regulate immunity and metabolism by activating the transcription factor (TF) activity of glucocorticoid receptor (GR). Previous models have proposed that DNA binding motifs and sites of chromatin accessibility predetermine GR binding and activity. However, there are vast excesses of both features relative to the number of GR binding sites. Thus, these features alone are unlikely to account for the specificity of GR binding and activity. To identify genomic and epigenetic contributions to GR binding specificity and the downstream changes resultant from GR binding, we performed hundreds of genome-wide measurements of TF binding, epigenetic state, and gene expression across a 12-h time course of glucocorticoid exposure. We found that glucocorticoid treatment induces GR to bind to nearly all pre-established enhancers within minutes. However, GR binds to only a small fraction of the set of accessible sites that lack enhancer marks. Once GR is bound to enhancers, a combination of enhancer motif composition and interactions between enhancers then determines the strength and persistence of GR binding, which consequently correlates with dramatic shifts in enhancer activation. Over the course of several hours, highly coordinated changes in TF binding and histone modification occupancy occur specifically within enhancers, and these changes correlate with changes in the expression of nearby genes. Following GR binding, changes in the binding of other TFs precede changes in chromatin accessibility, suggesting that other TFs are also sensitive to genomic features beyond that of accessibility.

Indexed as

Enhancer Elements, GeneticHistone CodeNucleotide MotifsTranscriptional ActivationCell Line, TumorEpigenesis, GeneticHumansProtein BindingReceptors, GlucocorticoidTranscription FactorsReceptors, GlucocorticoidTranscription Factors

Identifiers

PMID30097539
PMCPMC6120625
OpenAlexW2887625843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.